Immunotherapy for Third Line Metastatic Colorectal Cancer
Clinical trial NCT04444622 · COMPLETED
Trial details
- NCT number
- NCT04444622
- Sponsor
- Mirror Biologics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-12
- Primary completion
- 2025-03-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.